secwatch.observer — SEC 8-K summary
======================================

Issuer:     TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK:        0000818686
Form:       8-K
Filed at:   2026-09-03T20:06:14+00:00
Accession:  0001193125-26-381879
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teva to terminate ADS program; ADSs exchange for NYSE-listed ordinary shares on Sept 14, 2026
--------------------------------------------------------------------------------

- Amendment No. 1 to deposit agreement executed Aug 31, 2026; each ADS exchanges for one ordinary share.
- ADS program termination effective at open of business Sept 14, 2026; all outstanding ADSs cancelled.
- Ordinary shares will be listed on NYSE; ADS holders become direct shareholders of Teva.
- Depositary Citibank, N.A. involved; ADR form updated accordingly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818686/000119312526381879/0001193125-26-381879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818686/000119312526381879/d174614d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-381879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer